$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Is afatinib effective and how to take it?
2025-10-19 11:44:20
Check Details
Is it necessary to take afatinib for early stage lung cancer? What are the adverse reactions?
2025-10-19 11:44:20
Check Details
Afatinib is a targeted drug of several generations. What diseases does it mainly treat?
2025-10-19 11:44:20
Check Details
What diseases does Osimertinib treat and is it effective?
2025-10-19 11:44:20
Check Details
Is Dacomitinib effective? How much does it cost per bottle?
2025-10-19 11:44:20
Check Details
What is the difference between osimertinib and dacomitinib, which drug is more effective?
2025-10-19 11:44:20
Check Details
What causes diarrhea while taking dacomitinib and how to deal with it?
2025-10-19 11:44:20
Check Details
How to distinguish the authenticity of crizotinib?
2025-10-19 11:44:20
Check Details
Can aletinib cure lymphoma? Will smoking affect the efficacy of the medicine?
2025-10-19 11:44:20
Check Details
Tarceva 2023 price
2025-10-19 11:44:20
Check Details
What should not be eaten while taking aletinib and what precautions should be taken?
2025-10-19 11:44:20
Check Details
Tarceva side effects
2025-10-19 11:44:20
Check Details
1
2
...
4111
4112
4113
4114
4115
4116
4117
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Revolutionary Targeted Therapy for Hematological Malignancies
2
A New Option for Advanced Renal Cell Carcinoma Treatment
3
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
4
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
5
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
6
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
7
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
8
Comprehensive Analysis of the Third-Generation EGFR-TKI
9
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
10
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
11
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
12
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient